Patent · US Active

Crystalline form VI of agomelatine, preparation method and application thereof

US8614251B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2010
Grant dateDec 24, 2013
Priority date
Expiry dateAug 6, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C233/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a new crystalline form of agomelatine, preparation and use thereof. The X-ray powder diffraction diagram of the agomelatine crystalline form shows main peaks at the diffraction angles 2θ 11.13°, 11.82°, 17.49°, 18.29°, 19.48°, 19.72°, 20.50°, 21.76°, 22.54°, 22.97°, 24.56°, 25.36°, 27.16° and 31.93°. Said new crystalline form is characterized by high purity, stability and good reproducibility, and thus is advantageous for the pharmaceutical formulation. In addition, the stability and solubility of said crystalline form are also superior over the several existing crystalline forms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.